Hikma Pharmaceuticals PLC - Company & Market Research Reports

Home /
Companies /
Hikma Pharmaceuticals PLC

Hikma Pharmaceuticals manufactures a broad range of branded and non-branded generic pharmaceutical products across the United States, Middle East and Europe. The company’s operations span 29 manufacturing plants in 11 countries. It was founded by Samih Darwazah in 1978 in Amman in Jordan. In August 1996 it became the first Arab company to export pharmaceutical products to the United States.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 38
Generic Drugs 35
Central Nervous System Drugs 32
Analgesics 32
Anesthetic Drugs 29
Cardiovascular Drugs 28
Immune Disorders Drugs 27
Infectious Diseases Drugs 26
Respiratory Drugs 21
Musculoskeletal Disorders Drugs 21
Infusions and Injectables 20
Pharmaceuticals 17
Addiction Disorders Drugs 13
Gastrointestinal Drugs 13
Endocrine and Metabolic Disorders Drugs 13
Lung Cancer Drugs 10
Breast Cancer Drugs 10
Bladder Cancer Drugs 10
Biopharmaceuticals 9
Over the Counter (OTC) Drugs 9
Hematological Drugs 9
Antibiotics 9
Mental Disorders Drugs 8
Urological Disorders Drugs 8
Sexual and Reproductive Health Drugs 8
Ovarian Cancer Drugs 7
Thyroid Cancer Drugs 7
Drugs by Therapeutic Area 6
Liver Cancer Drugs 6
Biosimilars and Biosuperiors 6
Pharmaceutical Manufacturing 6
Immunosuppressive Drugs 6
Transdermal and Transmucosal Drug Delivery 5
Pancreatic Cancer Drugs 5
Allergy Drugs 5
Company Reports 4
Optical Disorders Drugs 4
Drug Discovery 4
Diabetes Drugs 4
Colon Cancer Drugs 4
Cough and Cold Drugs 4
Drug Delivery 4
Liver and Kidney Disorders Drugs 4
Skin Cancer Drugs 4
Vitamins and Dietary Supplements 4
Animal Pharmaceuticals 3
Prostate Cancer Drugs 3
Leukemia Drugs 3
Lymphoma Drugs 3
Inhalers and Nebulisers 3
Kidney Cancer Drugs 3
Bronchitis Drugs 3
Psoriasis Drugs 3
Pharmaceutical Intermediates 2
Cervical Cancer Drugs 2
Brain Cancer Drugs 2
Dermatological Drugs 2
Anxiety Drugs 2
Asthma Drugs 2
Clinical Trials 1
Vaccines 1
Uterine Cancer Drugs 1
Acne Drugs 1
Alzheimer's Disease Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



280 reviews

415 Results (Page 6 of 21)
- Relevance
  Sort by

Orthostatic Hypotension Drugs - Global Strategic Business Report

 Report
August 2025
286 Pages
Global

From

€5174EUR$5,850USD£4,467GBP

Cardiotonic Agents - Global Strategic Business Report

 Report
August 2025
568 Pages
Global

From

€5174EUR$5,850USD£4,467GBP

Immunosuppressants Market Report 2025

 Report
April 2025
175 Pages
Global

From

€3971EUR$4,490USD£3,428GBP

Corticosteroids Market Report 2025

 Report
April 2025
175 Pages
Global

From

€3971EUR$4,490USD£3,428GBP

Antiemetic Drugs Market by Indication, Drug Class, Route Of Administration, End User, Distribution Channel - Global Forecast 2025-2030

 Report
August 2025
181 Pages
Global

From

€3135EUR$3,545USD£2,707GBP

€3484EUR$3,939USD£3,008GBP

NEED HELP FINDING THE RIGHT PRODUCT? Olha will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Peptic Ulcer Drugs Market by Route Of Administration (Oral, Parenteral), Sales Channel (Over The Counter, Prescription Drugs), Brand Type, Dosage Form, End User, Distribution Channel, Drug Class - Global Forecast 2025-2030

 Report
August 2025
192 Pages
Global

From

€3135EUR$3,545USD£2,707GBP

€3484EUR$3,939USD£3,008GBP

Pharmaceutical Suspension - Global Strategic Business Report

 Report
August 2025
467 Pages
Global

From

€5174EUR$5,850USD£4,467GBP

Uveitis Drugs Market 2024-2028

 Report
August 2024
143 Pages
Global

From

€2211EUR$2,500USD£1,909GBP

Omega 3 Prescription Drugs - Global Strategic Business Report

 Report
August 2025
378 Pages
Global

From

€5174EUR$5,850USD£4,467GBP

Sterile Injectable Contract Manufacturing - Global Strategic Business Report

 Report
August 2025
387 Pages
Global

From

€5174EUR$5,850USD£4,467GBP

Small Volume Parenteral - Global Strategic Business Report

 Report
August 2025
483 Pages
Global

From

€5174EUR$5,850USD£4,467GBP

Hypercalcemia Treatment Market by Therapy Type (Bisphosphonates, Calcimimetics, Diuretics), Route Of Administration (Intravenous, Oral, Subcutaneous), End User, Patient Group, Distribution Channel - Global Forecast 2025-2030

 Report
August 2025
184 Pages
Global

From

€3135EUR$3,545USD£2,707GBP

€3484EUR$3,939USD£3,008GBP

Global Narcolepsy Drugs Market (By Therapeutic Type, Disease Type, End User, Regional Analysis), Pipeline Analysis, Key Company Profiles and Recent Developments - Forecast to 2030

 Report
January 2024
172 Pages
Global

From

€1937EUR$2,190USD£1,672GBP

Bacteriostatic Water for Injection - Global Strategic Business Report

 Report
August 2025
370 Pages
Global

From

€5174EUR$5,850USD£4,467GBP

Autoimmune Hemolytic Anemia Therapeutics Market 2024-2028

 Report
June 2024
145 Pages
Global

From

€2211EUR$2,500USD£1,909GBP

Anticoagulant Reversal Drugs Market by Reversal Agent Type (Andexanet Alfa, Ciraparantag, Idarucizumab), Route Of Administration (Intravenous, Oral), End User, Distribution Channel, Application - Global Forecast 2025-2030

 Report
August 2025
186 Pages
Global

From

€3135EUR$3,545USD£2,707GBP

€3484EUR$3,939USD£3,008GBP

Orthostatic Hypotension Drugs Market 2024-2028

 Report
December 2024
172 Pages
Global

From

€2211EUR$2,500USD£1,909GBP

Anesthesia Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

 Report
October 2024
98 Pages
Global

From

€3500EUR$4,240USD£3,128GBP

Inhalation Anesthesia Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

 Report
October 2024
91 Pages
Global

From

€3500EUR$4,240USD£3,128GBP

Catecholamines - Global Strategic Business Report

 Report
August 2025
372 Pages
Global

From

€5174EUR$5,850USD£4,467GBP

415 Results (Page 6 of 21)
- 1
- 4
- 5
- 6
- 7
- 8

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.